Hematocrit and the incidence of stroke: a prospective, population-based cohort study
Received 22 May 2018
Accepted for publication 14 September 2018
Published 23 October 2018 Volume 2018:14 Pages 2081—2088
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Professor Deyun Wang
Renling Yang,1,2 Anxin Wang,3–6 Li Ma,2 Zhaoping Su,7 Shuohua Chen,8 Yilong Wang,3–6 Shouling Wu,8 Chen Wang1,2
1Department of General Practice, School of General Practice and Continuing Education, Capital Medical University, Beijing, China; 2Department of General Practice, Beijing Tiantan Hospital, Capital Medical University, Beijing, China; 3Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China; 4China National Clinical Research Center for Neurological Diseases, Beijing, China; 5Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China; 6Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China; 7Department of Epidemiology and Health Statistics, Academy of Public Health and Management, Weifang Medical University, Weifang, China; 8Department of Cardiology, Kailuan Hospital, North China University of Science and Technology, Tangshan, China
Background and purpose: Whether higher hematocrit levels could increase the incidence of stroke has always been full of controversy. This study aimed to explore the association between hematocrit and the incidence of stroke in the Chinese population.
Subjects and methods: The Kailuan study is a prospective longitudinal cohort study on risk factors and events of chronic diseases. Using a multivariable Cox proportional hazards analysis, we examined the association between baseline hematocrit values and the incidence of stroke in the Kailuan cohort (93,299 participants).
Results: A total of 3,624 participants developed stroke during the 9-year follow-up period. In Cox regression models adjusted for demographic information and for clinical variables, there was a significant association between baseline hematocrit levels and the incidence of stroke. The highest hematocrit quartile (quartile 5: men, hematocrit >48.6%; women, hematocrit >43.2%) was associated with a higher incidence of stroke (HR 1.17, 95% CI 1.04–1.31, P for trend =0.0016) compared with the lowest hematocrit quartile (quartile 1: men, hematocrit <41.5%; women, hematocrit <36.6%). In the analysis of ischemic stroke, intracerebral hemorrhage separately, similar association was observed in ischemic stroke, but there were no statistical differences in intracerebral hemorrhage.
Conclusion: Higher hematocrit levels are associated with a higher incidence of stroke in the Chinese population.
Keywords: hematocrit, stroke, cohort
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]